Director GI Analytics
Revolution Medicines
Director GI Analytics
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Senior Director, GI Analytics & Insights, the Director, GI Analytics will serve as the analytics lead for Revolution Medicines’ GI cancer portfolio.
This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.
The role requires a strong understanding of the PDAC and CRC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.
This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Responsibilities include:
Lead analytics strategy and execution for Revolution Medicines’ GI cancer portfolio.
Partner with cross-functional stakeholders to identify key business questions and translate them into analytical plans and actionable recommendations.
Generate insights from patient-, physician-, claims-, EMR-, and market-level data to inform portfolio strategy, launch planning, and commercial decision-making.
Develop analyses to understand patient identification, biomarker testing patterns, treatment sequencing, referral pathways, and barriers to adoption.
Conduct market opportunity assessments, patient journey analyses, and competitive landscape evaluations to support strategic planning.
Design and execute segmentation, targeting, and opportunity identification analyses to inform customer engagement strategies.
Monitor evolving standards of care, treatment dynamics, and competitor activity across GI cancer indications.
Partner with Forecasting, Market Research, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
Lead development of key performance metrics, dashboards, and launch readiness assessments.
Inform data acquisition and data strategy decisions to ensure availability of fit-for-purpose oncology data assets.
Manage external analytics vendors and ensure timely delivery of high-quality analyses.
Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
Represent Revolution Medicines’ values in all internal and external interactions.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree preferred.
8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
Oncology analytics experience required; GI cancer (PDAC and/or CRC) experience strongly preferred.
Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
Experience supporting oncology product launches and pre-launch planning.
Strong analytical, problem-solving, and strategic thinking skills.
Proven ability to influence cross-functional teams and senior leadership.
Excellent communication and presentation skills.
Ability to thrive in a fast-paced, entrepreneurial environment.
Preferred Skills:
MBA, MPH, MS, or PhD.
Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
Experience supporting targeted oncology therapies.
Experience with advanced analytics, predictive modeling, AI/ML applications, or commercial forecasting.
Prior experience in a growth-stage biotechnology company.
#LI-JW1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 211000 - 264000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines